(19)

(11)

EP 4 486 349 A1

(12)

(43) Date of publication: 08.01.2025 Bulletin 2025/02 (21) Application number: 23707407.5 (22) Date of filing: 01.03.2023

(51) International Patent Classification (IPC):  A61K 31/519(2006.01) A61K 9/00(2006.01) A61P 17/14(2006.01) A61P 15/10(2006.01) A61P 17/00(2006.01) (52) Cooperative Patent Classification (CPC): A61P 17/14; A61P 15/10; A61P 17/00; A61K 9/0014; A61K 31/519; A61K 47/10; A61Q 7/00; A61Q 19/08; A61K 8/494 (86) International application number: PCT/EP2023/055085 (87) International publication number: WO 2023/166013 (07.09.2023 Gazette 2023/36)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 02.03.2022 EP 22159773 (71) Applicant: Topadur Pharma AG 8952 Schlieren (CH)	(72) Inventors: NAEF, Reto 4310 Rheinfelden (CH) ATZEI, Paola 8952 Schlieren (CH) FRANCISCO, Rita 8006 Zürich (CH) (74) Representative: Latscha Schöllhorn Partner AG  Grellingerstrasse 60 4052 Basel 4052 Basel (CH)